IP Library Granted Patent US 10,716,764
Granted Patent B2
US 10,716,764 · App. 15/385,638 · Granted Jul 21, 2020

Transdermal drug delivery method and system

Inventors: Werner Zumbrunn (Muttenz, CH); Georgios Imanidis (Bottmingen, CH); Guy DiPierro (San Francisco, CA); Hans Werner Van De Venn (Winterthur, CH)
Assignee: Morningside Venture Investments Limited
A61K31/00A61K9/0009A61K9/0014A61K9/703A61K31/04A61K31/137A61K31/465A61M37/00A61M37/0015A61M39/22A61M37/0092A61M2037/0007A61M2037/0023A61M2037/0061A61M2205/0266A61M2205/3337A61M2205/50A61N1/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,716,764
App. No.
15/385,638
Granted
Jul 21, 2020
Kind
B2
Abstract

The invention concerns a transdermal delivery system for controlled dispensing of an active substance to and through a porous surface. A certain amount of fluid comprising at least one active substance and at least one solvent is dispensed into an administration reservoir. In the administration reservoir the at least one solvent is separated from the administration reservoir by a solvent recovery means such that the active substance achieves a certain level on an interface device which is permeable for the one active substance. Thereby the active substance is absorbable via diffusion from the interface device by a porous surface to be treated.

Claims (25)

1. A device for transdermal administration of an active substance, the device comprising:

a pressurized reservoir;

a solution of the active substance and a solvent disposed in the pressurized reservoir;

a porous skin interface adapted to receive solution from the reservoir and to transfer active substance to skin; and

a solvent recovery element communicating with the skin interface and adapted to receive evaporated solvent from the skin interface.

2. The device of claim 1 wherein the solvent recovery element comprises desiccant or absorbent material.

3. The device of claim 1 further comprising a vapor permeable material disposed between the skin interface and the solvent recovery element.

4. The device of claim 1 further comprising a piston disposed in the pressurized reservoir in contact with the solution.

5. The device of claim 1 further comprising a valve controlling flow of solution from the pressurized reservoir to the skin interface.

6. The device of claim 5 further comprising a programmable control unit adapted to control the valve.

7. The device of claim 1 wherein the skin interface comprises adhesive.

8. The device of claim 1 further comprising a housing into which the pressurized reservoir, porous skin interface and solvent recovery element are incorporated.

9. The device of claim 1 further comprising an administration reservoir adapted to receive the solution from the pressurized reservoir and to communicate with the porous skin interface.

10. A method for transdermally administering an active substance to a subject, the method comprising:

placing a porous skin interface of a transdermal dispensing system into contact with the subject's skin;

dispensing a solution of the active substance and a solvent from a pressurized reservoir of the dispensing system to the porous skin interface;

delivering the active substance through the porous skin interface to the subject's skin; and

moving solvent from the porous skin interface into a solvent recovery element of the dispensing system.

11. The method of claim 10 wherein the moving step comprises moving solvent into desiccant or an absorbent material of the solvent recovery element.

12. The method of claim 10 wherein the moving step comprises moving solvent through a vapor permeable material into the solvent recovery element.

13. The method of claim 10 wherein the dispensing step comprises moving a piston within the pressurized reservoir.

14. The method of claim 10 wherein the dispensing step comprises actuating a valve to control flow of solution from the pressurized reservoir to the skin interface.

15. The method of claim 14 wherein the actuating step comprises actuating the valve automatically according to a preset administration regime.

16. The method of claim 10 wherein the dispensing step comprises flowing the solution from the pressurized reservoir into an administration reservoir before reaching the porous skin interface.

17. The method of claim 10 further comprising adhesively attaching the dispensing system to the subject.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: MORNINGSIDE VENTURE INVESTMENTS LIMITED
Reel/Frame 055382/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CHRONO THERAPEUTICS, INC.
To: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 055384/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: ZUMBRUNN, WERNER
To: FACHHOCHSCHULE SOLOTHURN
Reel/Frame 045450/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: IMANIDIS, GEORGE; DIPIERRO, GUY
To: CHRONO THERAPEUTICS INC.
Reel/Frame 045450/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: VAN DE VENN, HANS WERNER
To: FACHHOCHSCHULE SOLOTHURN
Reel/Frame 045450/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: FACHHOCHSCHULE NORDWESTSCHWEIZ, FORMERLY FACHHOCHSCHULE SOLOTHURN
To: UNIVERSITY OF BASEL
Reel/Frame 045451/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: UNIVERSITY OF BASEL AND THE UNIVERSITY OF APPLIED SCIENCE NORTHWESTERN SWITZERLAND AKA FHSO AND FACHHOCHSCHULE SOLOTHURN
To: CHRONO THERAPEUTICS INC.
Reel/Frame 045451/0258 →
Priority Claims (1)
CH 1833/03 · Oct 27, 2003 · national
Continuity (6)
Continuation 14746689 · Jun 22, 2015
Continuation 14162156 · Jan 23, 2014
Continuation 13892006 · May 10, 2013
Division 10711389 · Sep 15, 2004
Continuation PCTIB2004002947 · Sep 13, 2004
Related Publication 20170100572A1 · Apr 13, 2017
Cited By (4)
US 12,397,141 US 12,515,030 US 12,629,503 US 12,649,029